Trial on the Acceptability of Modified Lipid Based Nutrient Supplements Among Malawian Infants (iLiNS-ACCEPT-M)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The use of lipid-based nutrients (LNS), such as Nutributter or fortified spread (FS), have been associated with improved growth and development outcomes among infants in Ghana and Malawi. The investigators' study group has developed modified versions of such supplements that theoretically will supplement infants diets better and with lower cost. As a preparation for larger efficacy trials, the investigators now aim to test the acceptability of these supplements among Malawian infants and their guardians. The trial hypothesis is that the infants will consume on average at least 50% of an offered dose that consists of LNS mixed with maize porridge.
| Condition | Intervention | Phase |
|---|---|---|
|
Malnutrition |
Dietary Supplement: Nutributter Dietary Supplement: LNS-20gM Dietary Supplement: LNS-20gNoM Dietary Supplement: LNS-10gM |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Caregiver, Outcomes Assessor) Primary Purpose: Prevention |
| Official Title: | Differential Acceptability of New Lipid Based Nutrient Supplement (LNS) Formulations for Prevention of Moderate Malnutrition |
- Mean amount (in grammes) of test food consumed [ Time Frame: within 15 minutes of test feeding ] [ Designated as safety issue: No ]
- Mean time taken to consume the intervention dose [ Time Frame: 15 minutes after test feeding ] [ Designated as safety issue: No ]
- Mean rating by the guardians (on a hedonic, 5 point scale) [ Time Frame: 15 minutes after test feeding ] [ Designated as safety issue: No ]
- Overall guardian feedback after a two week supplementation period (qualitative analysis of focus group discussions) [ Time Frame: Once, when the children have completed a two-week supplementary feeding period ] [ Designated as safety issue: No ]
| Enrollment: | 19 |
| Study Start Date: | April 2009 |
| Study Completion Date: | June 2009 |
| Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
-
Dietary Supplement: Nutributter
In the first phase, 18 infants meeting set criteria are randomised into receiving three test meals with novel LNS preparations over a three-day period. The meals will consists of the following, each given on one day and in a random order: 1) 7.5 g of LNS-10gM mixed in 30 g maize-soy porridge, 2) 15 g of LNS-20gM mixed in 30 g maize-soy porridge, 3) 15 g of LNS-20gNoM mixed in 30 g maize-soy porridge. As a run in procedure, each participant will undergo a test feeding session with one of the the test foods on the day before the actual test-feeding period. As a positive control, each participant will undergo test feeding session with standard Nutributter (NB) on the day after the actual test-feeding period.
In the second phase a set of 48 infants are randomised into 3 groups receiving the following food supplements for a period of 2 weeks: 1) 10 g/day of milk-containing, very concentrated LNS (LNS-10gM), 2) 20 g/day of milk-containing, concentrated LNS (LNS-20gM), 3) 20 g/day of milk-free, concentrated LNS (LNS-20 g NoM)
Outcomes measures in the first phase will be assessed through safety reports and quantities of test food consumed by the child and a hedonic scale of acceptability by the mothers of the children. The second phase will be assessed with qualitative outcomes, from data obtained from focus group discussions with the guardians of the infants consuming the test foods.
Eligibility| Ages Eligible for Study: | 8 Months to 12 Months |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Signed informed consent from at least one guardian
- Age 7.50 months to 11.49 months
- Currently breastfeeding
- Consuming complementary feeds at least 30 days prior to enrollment
- Availability during the period of the study
Exclusion Criteria:
- Weight for length Z score (WFH) ≤ -2.0 using WHO growth reference standards or the -presence of oedema
- Severe systemic illness warranting hospital referral
- History of allergy towards peanut
- History of anaphylaxis or serious allergic reaction to any substance, requiring emergency medical care
- Congenital malformation such as cleft palate which may interfere with food intake
- Concurrent participation in any other clinical trial
Contacts and Locations| Malawi | |
| University of Malawi, College of Medicine | |
| Mangochi, Malawi | |
| Principal Investigator: | Per Ashorn, MD, PhD | University of Tampere |
| Principal Investigator: | Kenneth Maleta, MBBS, PhD | University of Malawi College of Medicine |
More Information
Additional Information:
No publications provided
| Responsible Party: | Per Ashorn / Professor of International Health, University of Tampere |
| ClinicalTrials.gov Identifier: | NCT00885144 History of Changes |
| Other Study ID Numbers: | iLiNS-ACCEPT-M |
| Study First Received: | April 20, 2009 |
| Last Updated: | June 23, 2009 |
| Health Authority: | Malawi: College of Medicine Research and Ethics Committee |
Keywords provided by University of Tampere:
|
Stunting Growth failure Malnutrition Lipid based nutrient supplement LNS |
Prevention Malawi Sub-Saharan Africa Dietary supplementation |
Additional relevant MeSH terms:
|
Malnutrition Nutrition Disorders |
ClinicalTrials.gov processed this record on May 16, 2013